Dana L. Johnson

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

Allan W. Bach, N C Lan, Dana L. Johnson et al. · Proceedings of the National Academy of Sciences · 1988 · 725 citations · Full text

Neuropeptides, Enzymatic Properties, Biochemistry +15

Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation

Oded Livnah, E.A. Stura, Steven A. Middleton et al. · Science · 1999 · 596 citations

Crystal Structure, Crystallographic Evidence, Actual Dimer Configuration +20

Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å

Oded Livnah, E.A. Stura, Dana L. Johnson et al. · Science · 1996 · 592 citations

An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation

Oded Livnah, Dana L. Johnson, E.A. Stura et al. · Nature Structural Biology · 1998 · 217 citations

Molecular Pharmacology, Antagonist Peptide–epo Receptor, Signal Transduction +7

Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation <i>in vitro</i> and sensitize tumors to doxorubicin <i>in vivo</i>

Holly K. Koblish, Shuyuan Zhao, Carol F. Franks et al. · Molecular Cancer Therapeutics · 2006 · 162 citations · Full text

P53 Interaction, Chemoprevention Strategy, P53 Complex +18